IBA introduces Proton Therapy solutions for cancer
The Proteus series of Proton Therapy solutions offer radiotherapy with fewer clinical consequences and is expected to treat 250 to 2,000 patients annually with protons. The solution comprises
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.